by kwal1 | Jul 19, 2016 | News
SurgiMab will attend WMIC 2016 : Bérénice Framery, in charge of the company’s internal R&D programs, will be present in New York. You can meet her in particular during the “Optical Surgical Navigation” session on Wednesday, September 7, 2016,...
by kwal1 | May 12, 2016 | News
Let’s meet at the Moscone Center in San Francisco, June 6-9 for the BIO International convention! The company presentation will take place in Room 4 on Wednesday the 8th, 5:00 PM during the Oncology session. Françoise Cailler, CEO of the company, will update the...
by kwal1 | Feb 13, 2016 | News
SurgiMab is happy to be part of the sponsors for the conference “Molecular Guided Surgery : Molecules, Devices and Applications II”, organized par Brian W. Pogue and Sylvain Gioux as a part of the SPIE photonics West meeting that will take place at the...
by kwal1 | Feb 5, 2016 | News
Montpellier, France, February 5th, 2016. SurgiMab announces the launch of a phase I clinical trial program evaluating the safety and performance of its fluorescent conjugate SGM-101 in patients with pancreatic or rectal cancer. SurgiMab, founded in 2011 in...
by kwal1 | Sep 2, 2015 | News
SurgiMab is happy to be part of the sponsors for the one-day Optical Surgical Navigation Seminar that is organized on september the 2nd during the World Molecular Imaging Congress in Hawaï. SurgiMab will also present its latest results on September 3rd during the WMIC...
by kwal1 | May 15, 2015 | News
SurgiMab, a French company founded in 2011 in Montpellier, is developing antibody-fluorochrome conjugates as in vivo diagnostic agents in oncology. “Today we are pleased to announce that Montpellier Cancer Institute (ICM) has started patient inclusion in a phase I...
